News & Blogs
Exploring nutraceutical trends for 2027 and beyond
November 12, 2026

Table of Contents

As 2027 rapidly approaches, consumer demand for better gut health shows no sign of slowing down.

More than 80% of consumers in the UK, US and China consider gut health important, according to prior McKinsey’s Future of Wellness research, and almost every major 2027 market forecast puts the gut microbiome close to the centre of innovation.

For formulators, that success brings a new challenge. With more gut health products on shelf than ever, how does a new launch stand out?

Mintel’s Global Predictions 2027 report offers a useful way to think about it, describing a shift from ‘products to systems’, in which consumers start with the outcome they want, such as better sleep, healthier ageing or more everyday energy. Then, they work backwards from there by combining the products and habits that will help them reach that outcome. Through this lens, gut health itself is not the outcome, but the system behind many of them.

In this blog, we explore five trends set to shape biotics formulation in 2027, and where a well-evidenced prebiotic can help formulators and brands to capture attention.

Feeding the microbiome: bridging the fibre gap

The gut health category has largely grown on the back of probiotics. A recent University of Michigan study, published in Clinical Gastroenterology and Hepatology, found adult probiotic supplement use in the US rose by 287% between 2009 and 2023. Over the same period, fibre intake stayed well below recommended levels.

This is a gap that prebiotics can help to fill. By selectively nourishing beneficial bacteria, particularly bifidobacteria, prebiotics can support both the microbes already present in the gut, and those introduced through supplements. As explored in our fibremaxxing blog, consumers are becoming more fibre-aware, but not all fibres are prebiotic, and not all prebiotics work at the same dose.

For formulators, Bimuno® GOS offers a practical route to closing the fibre gap. It has demonstrated a bifidogenic effect at an ultra-low dose of just 380mg active GOS per day, with gastrointestinal benefits from 1.37g. That makes it useful for capsules, gummies and multi-ingredient formulas where space is tight, as well as a natural partner for probiotic strains in synbiotic products.

Longevity: adding life to years

Healthy ageing is being redefined. Increasingly framed as longevity, it is no longer only about later life, but about making sure those extra years are lived in good health and investing in that from midlife or earlier. The goal is not to add years to life but add life to those years.

An analysis of 183 countries, published in JAMA Network Open, found the gap between lifespan and healthspan, the years lived in good health, had reached 9.6 years globally and 11.3 years in the UK. The market is responding too; Innova Market Insights reports that launches with ageing-well claims grew 55% in the year to June 2026.

The gut microbiome is a natural fit for this approach to longevity. Levels of beneficial bifidobacteria tend to decline with age, and immune function gradually weakens in a process known as immunosenescence. In clinical studies of healthy older adults, 2.75g of Bimuno GOS daily for 10 weeks was shown to support immune health and a more balanced inflammatory response.

For longevity products designed to be taken every day for years, it is vital to combine clinical evidence, low dose versatility, and format flexibility.

Active nutrition outgrows sports nutrition

The sports nutrition category initially centred almost exclusively on athletes. Its successor, active nutrition, is built for everyone from gymgoers and runners to people focused on staying strong as they age. Innova finds that over a third of consumers globally want help to stay strong as they age and launches pairing ageing-well and protein claims grew 94% year on year reflecting the demand.

Gut health is the next frontier in active nutrition. The gut–muscle axis was a recurring theme at Vitafoods Asia this year, and digestive comfort matters to anyone increasing their protein intake.

Bimuno GOS has been studied directly in athletes. In a six-week, double-blind, placebo-controlled study at Nottingham Trent University, published in Experimental Physiology, team-sport athletes took Bimuno GOS daily before completing a simulated football match in the heat.

Compared with placebo, the Bimuno GOS group showed:
• Upper respiratory episodes lasting 3.2 days on average, against 8.9 days, with symptoms almost three times less severe
• A reduction in a biomarker of gut barrier damage after exercise
• Higher salivary IgA, a key immune defence marker, after exercise

The results of the study have been explored in a video that breaks down what these results mean in terms of supporting athletic health. Click here to watch it.

With its stability and neutral taste, Bimuno GOS can be used in a wide range of product formats, including sports powders, bars and recovery drinks.

Drinkable biotics: hydration and the next generation of prebiotic RTDs

Hydration has become a wellness occasion in its own right, stretching from water and sports drinks to electrolyte sachets, functional waters and dairy drinks. As consumers look for health benefits they can take on the go, drinks are a natural next step for gut health.

Prebiotics carry certain structural advantages over live cultures here; there is no viable microbial count to protect through processing and shelf life. While still emerging, the category has faced scrutiny for doses so low that consumers would need several cans a day to see a benefit. With so much potential in this category, the next generation of prebiotic RTDs will need to deliver an effective dose without compromising taste or texture.

Bimuno GOS is well suited to that need:
• Effective at a low dose: Verified health effects from 1.37g active GOS per day, which fits a single serving
• Process stable: stable at boiling point, through UHT processing and across a wide pH range
• Easy on the palate: a mild, slightly sweet taste and good dispersibility, needing little or no flavour masking

From prebiotic hydration powders to dairy RTDs and functional waters, these properties support the development of products that combine gut health with the outcomes consumers already link to drinking, such as hydration, energy and recovery. Read our hot weather blog to explore the hydration opportunity in detail.

Evidence takes centre stage

As gut health demand grows so does the commercial buzz around it, and consumers are looking harder for proof. In the Council for Responsible Nutrition’s 2026 consumer survey, 81% of US adults said scientific evidence is important when deciding whether a supplement is right for them. McKinsey’s Future of Wellness research explores the same shift, with consumers prioritising clinically proven ingredients.

In biotics, structures and doses are not interchangeable, and one ingredient cannot borrow another’s results. Evidence generated on a generic GOS, or on prebiotics as a category, does not automatically apply to a specific commercial ingredient.

Bimuno GOS is the most extensively studied prebiotic in the GOS category for adult nutrition, backed by more than 135 scientific publications, including over 25 clinical studies. The research behind it spans gastrointestinal, immune, cognitive, metabolic and sports nutrition outcomes, giving brands and their formulators evidence tied to the exact ingredient in their product.

Building for 2027 and beyond

In a health and nutrition market organised around outcomes, the most valuable ingredients will be those that can offer proven efficacy in many systems: longevity routines, active lifestyles, everyday drinks, and daily supplements. A low effective dose, proven stability and a comprehensive evidence base give Bimuno GOS that versatility.

Planning your 2027 health product launches? Speak to the Clasado team about Bimuno GOS, its evidence base and the formulation support available for your application.

Frequently Asked Questions

Key trends include closing the fibre gap, longevity and healthy ageing, active nutrition, prebiotic drinks and a growing demand for clinical evidence. Across all of them, consumers are choosing products based on the outcomes they want, with gut health supporting many of those outcomes.

The fibre gap describes the shortfall between recommended fibre intake and what most people actually eat. It matters for gut health because beneficial gut bacteria rely on fermentable fibres, including prebiotics, as their food source.

Unlike live probiotic cultures, prebiotics have no viable count to protect through processing and storage. Stable prebiotics such as Bimuno GOS hold up through heat, acidity and shelf life, making them easier to formulate into RTDs and functional waters.

Related Posts

Read the Clasado Blog